PULMONARY TUBERCULOSIS
Clinical trials for PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New TB drug could cut treatment time to 4 months
Disease control Recruiting nowThis study tests whether a new drug called quabodepistat, combined with other TB medicines, can treat drug-resistant tuberculosis (TB) in just 4 months instead of the usual 6 months. About 532 adults and teens with rifampicin-resistant or multidrug-resistant TB will take part. Th…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 17, 2026 06:21 UTC
-
Could a 2-Month pill regimen beat TB in all forms?
Disease control Recruiting nowThis study tests a new ultra-short treatment (2-3 months) for both drug-sensitive and drug-resistant active tuberculosis (TB). About 610 adults with confirmed TB will receive either the new regimen or standard care. The goal is to see if the shorter treatment works as well or bet…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE3 • Sponsor: Shenzhen Third People's Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New TB cocktails aim to speed up cure in groundbreaking trial
Disease control Recruiting nowThis study tests new combinations of TB drugs to see if they work better than the standard treatment. About 390 adults with newly diagnosed, drug-sensitive TB will take part. The goal is to find shorter or more effective ways to clear the infection and prevent it from coming back…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could a 8-week TB treatment replace the standard 24-week regimen?
Disease control Recruiting nowThis trial tests new drug combinations to treat pulmonary tuberculosis (TB) faster than the standard 24-week treatment. About 2500 adults with TB will receive one of 11 combinations including two new drugs, BTZ-043 and GSK3036656, for 8 to 16 weeks. The goal is to find a safe, ef…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New TB cocktails aim to speed up recovery
Disease control Recruiting nowThis study tests new combinations of drugs for adults with lung tuberculosis (TB) to see if they work faster and are safer than the current standard treatment. About 315 participants will receive either a new drug mix or the usual treatment for 8 weeks, then all continue standard…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Could a common cholesterol drug help beat tuberculosis?
Disease control Recruiting nowThis study is testing whether adding the cholesterol-lowering drug atorvastatin to the usual antibiotics for tuberculosis (TB) can help clear the infection faster and reduce lung damage. About 440 adults with newly diagnosed, drug-sensitive pulmonary TB in Nigeria will receive ei…
Matched conditions: PULMONARY TUBERCULOSIS
Phase: PHASE2 • Sponsor: Obafemi Awolowo University Teaching Hospital • Aim: Disease control
Last updated May 08, 2026 12:01 UTC